| Volume 15, Issue 2 |
Spring 2009 |
|
Masthead
|
| The Law & Economics of Drug Development Symposium |
|
Does Misery Love Company? Evidence from Pharmaceutical Markets Before and After the Orphan Drug Act
|
Frank R. Lichtenberg & Joel Waldfogel |
|
Platitudes About "Product Stewardship" in Torts: Continuing Drug Research and Education
|
Lars Noah |
|
PDUFA and Initial U.S. Drug Launches
|
Mary K. Olson |
|
The Chinese Regulatory Licensing Regime for Pharmaceutical Products: A Law and Economics Analysis
|
Qing Zhang |
| Comment |
|
Why FDCA Section 505(u) Should Not Concern Us Greatly
|
Kyle Faget |
| Article |
|
Appellate Review of Patent Claim Construction: Should the Federal Circuit Be Its Own Lexicographer in Matters Related to the Seventh Amendment?
|
Eileen M. Herlihy |
| Notes |
|
FCC Jurisdiction over ISPs in Protocol-Specific Bandwidth Throttling
|
Andrew Gioia |
|
Legislation for Effective Self-Regulation: A New Approach to Protecting Personal Privacy on the Internet
|
Richard M. Marsh, Jr. |
|
When and How to Defer to the FDA: Learning from Michigan's Regulatory Compliance Defense
|
Jason C. Miller |